Evidence map›Paper›PMID 38720002›Full record

ArticleNature medicine2024

An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution.

Lorenzo Subissi, James Richard Otieno, Nathalie Worp, Homa Attar Cohen, Bas B Oude Munnink, Laith J Abu-Raddad, Erik Alm, Amal Barakat, Wendy S Barclay, Jinal N Bhiman and 48 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. SARS-CoV-2 NSP8-Derived Peptide Effectively Suppresses the Activity of Helicase NSP13.Computational and structural biotechnology journal · 2026
    Article
  6. Article
  7. Review
  8. Molecular mechanisms of SARS-CoV-2 entry: implications for biomedical strategies.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Decoding the cross-immune pressure: Dengue's role in SARS-CoV-2 evolution.Computational and structural biotechnology journal · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

58 authors.

Lorenzo SubissiWorld Health Organization, Geneva, Switzerland. subissil@who.int.ORCID 0000-0001-5147-575X
James Richard OtienoWorld Health Organization, Geneva, Switzerland.
Nathalie WorpErasmus Medical Centre, Rotterdam, the Netherlands.
Homa Attar CohenWorld Health Organization, Geneva, Switzerland.ORCID 0000-0002-5848-0778
Bas B Oude MunninkErasmus Medical Centre, Rotterdam, the Netherlands.ORCID 0000-0002-9394-1189
Laith J Abu-RaddadWeill Cornell Medicine-Qatar of Cornell University, Doha, Qatar.ORCID 0000-0003-0790-0506
Erik AlmEuropean Centre for Disease Prevention and Control, Stockholm, Sweden.ORCID 0000-0002-2903-607X
Amal BarakatWorld Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Wendy S BarclayImperial College London, London, UK.ORCID 0000-0002-3948-0895
Jinal N BhimanNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0001-6354-4003
Leon CalyVictorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australia.
Meera ChandUK Health Security Agency, London, UK.
Mark ChenNational Centre for Infectious Diseases, Singapore, Singapore.
Ann CullinaneWorld Organisation for Animal Health, Paris, France.
Tulio de OliveiraCentre for Epidemic Response and Innovation, Stellenbosch University, Stellenbosch, South Africa.ORCID 0000-0002-3027-5254
Christian DrostenCharité Medical Center, Berlin, Germany.ORCID 0000-0001-7923-0519
Julian DruceVictorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australia.
Paul EfflerUniversity of Western Australia, Perth, Western Australia, Australia.
Ihab El MasryFood and Agriculture Organization of the United Nations, Rome, Italy.
Adama FayeInstitut de Santé et Développement, Université Cheikh Anta Diop, Dakar, Senegal.
Elodie GhedinNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-1515-725X
Rebecca GrantWorld Health Organization, Geneva, Switzerland.
Bart L HaagmansErasmus Medical Centre, Rotterdam, the Netherlands.ORCID 0000-0001-6221-2015
Christian HappiAfrican Center of Excellence for Genomics of Infectious Disease, Redeemer's University, Ede, Nigeria.ORCID 0000-0002-3056-6705
Belinda L HerringWorld Health Organization Regional Office for Africa, Brazzaville, Republic of the Congo.
Emma B HodcroftSwiss Tropical and Public Health Institute, University of Basel, Basel, Switzerland.
Juniorcaius IkejezieWorld Health Organization, Geneva, Switzerland.
Victoria KataweraWorld Health Organization Regional Office for the Western Pacific, Manila, the Philippines.
Zyleen Alnashir KassamaliWorld Health Organization, Geneva, Switzerland.ORCID 0000-0002-0668-7099
Yee-Sin LeoNational Centre for Infectious Diseases, Singapore, Singapore.ORCID 0000-0003-4978-5825
Gabriel M LeungSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, The People's Republic of China.
Rebecca J KondorUnited States Centers for Disease Control and Prevention, Atlanta, GA, USA.
Marco MarklewitzWorld Health Organization Regional Office for Europe, Copenhagen, Denmark.ORCID 0000-0003-1828-8770
Jairo Mendez-RicoWorld Health Organization Regional Office for the Americas, Washington, DC, USA.
Nada M MelhemFaculty of Health Sciences, American University of Beirut, Beirut, Lebanon.ORCID 0000-0002-5423-4908
Vincent MunsterNational Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-2288-3196
Karen NahapetyanWorld Health Organization Regional Office for Europe, Copenhagen, Denmark.
Dhamari NaindooWorld Health Organization Regional Office for South East Asia, Delhi, India.
Djin-Ye OhRobert Koch Institute, Berlin, Germany.ORCID 0000-0003-0541-6155
Thomas P PeacockImperial College London, London, UK.ORCID 0000-0001-7077-2928
Malik PeirisSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, The People's Republic of China.ORCID 0000-0001-8217-5995
Zhibin PengChinese Center for Disease Control and Prevention, Beijing, The People's Republic of China.
Leo L M PoonSchool of Public Health, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, The People's Republic of China.ORCID 0000-0002-9101-7953
Andrew RambautUniversity of Edinburgh, Edinburgh, UK.ORCID 0000-0003-4337-3707
Senjuti SahaChild Health Research Foundation, Dhaka, Bangladesh.
Yinzhong ShenShanghai Public Health Clinical Center, Fudan University, Shanghai, The People's Republic of China.
Marilda M SiqueiraOswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Erik VolzImperial College London, London, UK.ORCID 0000-0001-6268-8937
Sofonias K TessemaAfrica Centers for Disease Control and Prevention, Addis Ababa, Ethiopia.
Volker ThielMultidisciplinary Center for Infectious Diseases, University of Bern, Bern, Switzerland.
Henda TrikiInstitut Pasteur Tunis, Tunis, Tunisia.
Sylvie van der WerfInstitut Pasteur, Université Paris Cité, Paris, France.ORCID 0000-0002-1148-4456
Karin von EijeWorld Health Organization, Geneva, Switzerland.ORCID 0000-0003-0627-5673
Jane CunninghamWorld Health Organization, Geneva, Switzerland.
Marion P G KoopmansErasmus Medical Centre, Rotterdam, the Netherlands.ORCID 0000-0002-5204-2312
Anne von GottbergNational Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa.ORCID 0000-0002-0243-7455
Anurag AgrawalTrivedi School of Biosciences, Ashoka University, Sonipat, India.
Maria D Van KerkhoveWorld Health Organization, Geneva, Switzerland.

Funding

Virus Ecology Unit - COVID-19 responseZIAAI001289 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI MUNSTER, VINCENT · 2020 to 2025
$4.7M
Determining factors of transmission and evolution of SARS-CoV-2 in populations at risk ZIAAI001324 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI GHEDIN, ELODIE · 2020 to 2025
$2.7M
Medical Research Council MR/X020258/1Wellcome Trust 206298/Z/17/ZWorld Health Organization 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Evolution, MolecularSARS-CoV-2Humans

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.